[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599413":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":28,"centralContacts":32,"locations":38,"responsibleParty":57,"collaborators":27,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":27,"eligibilityCriteria":64,"healthyVolunteers":61,"sex":65,"minAge":66,"maxAge":27,"enrollmentInfo":67,"targetDuration":27,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":77,"overallStatus":41,"whyStopped":27,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"UNC Lineberger Comprehensive Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Genetic Testing Awarness","EXPERIMENTAL","Educational videos about genetic testing will be provided for ovarian cancer and endometrial cancer.",[13,14],"Behavioral: Educational videos","Behavioral: Survey",[16,23],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"BEHAVIORAL","Educational videos","Educational videos about genetic testing will be provided. Subjects will be asked to view one of three videos (an endometrial cancer\u002FLynch Syndrome video or a longer or shorter version of an ovarian cancer video) relevant to their cancer diagnosis and genetic testing.",[9],[22],"Genetic testing information",{"type":17,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"Survey","Subjects will be asked to complete a brief satisfaction survey.",[9],null,[29],{"name":30,"affiliation":5,"role":31},"Katherine Tucker, MD","PRINCIPAL_INVESTIGATOR",[33],{"name":34,"role":35,"phone":36,"phoneExt":27,"email":37},"Luz Cuaboy","CONTACT","919-843-5400","luz_cuaboy@med.unc.edu",[39],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Univeristy of North Carolina at Chapel Hill","RECRUITING","Chapel Hill","North Carolina","27599","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-79.05584,35.9132,{"lat":51,"lon":50},[54,56],{"name":34,"role":35,"phone":55,"phoneExt":27,"email":37},"919-962-0070",{"name":30,"role":31,"phone":27,"phoneExt":27,"email":27},{"type":58,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100599413","multimedia-aid-for-genetic-testing-in-gynecologic-oncology-100599413",false,"NCT07084168","Multimedia Aid for Genetic Testing in Gynecologic Oncology","Inclusion Criteria:\n\nIn order to participate in this study, a subject must meet all of the eligibility criteria outlined below.\n\n* Reviewed informed consent to participate in the study.\n* Subject is willing and able to comply with study procedures based on the judgment of the investigator.\n* Age ≥ 18 years at the time of consent.\n* Diagnosis of ovarian cancer or endometrial cancer\n* Eligible for genetic testing\n* English or Spanish is the primary language\n\nExclusion Criteria:\n\n* Previously completed genetic testing\n* Did not receive initial cancer-directed treatment at study site","FEMALE","18 Years",{"count":68,"type":69},30,"ESTIMATED","INTERVENTIONAL",[72],"NA","This pilot study aims to estimate rates of genetic testing in patients with ovarian and endometrial cancer before and after the implementation of educational videos about genetic testing. Subjects will be asked to view one of three videos relevant to their cancer diagnosis and genetic testing, and have the option to complete a brief satisfaction survey. A chart review to evaluate rates of genetic testing ordered and referrals placed to Genetics before and after the implementation of the videos will be conducted.\n\nUp to 15-20% of ovarian cancer and 3-5% of endometrial cancer is due to inherited genetic mutation. Given this association, the National Comprehensive Cancer Network (NCCN) recommends genetic counseling and testing for all individuals with a diagnosis of ovarian cancer and endometrial cancer. Some challenges to obtaining genetic counseling and testing include missed identification and referral of eligible patients by providers, lack of provider knowledge, and busy clinic visits limiting time for informed consent and maintaining patient autonomy for genetic testing. Although heterogeneous, the literature supports multimedia use in cancer genetics. However, there is a paucity of data in the field of gynecologic oncology for the role of integrating a multimedia approach to genetic counseling.",[75,76],"Ovary Cancer","Endometrial Cancer",[78,79,80],"genetic testing","video implementation","chart review","2025-11-10",{"date":83,"type":84},"2025-11-12","ACTUAL",{"date":86,"type":84},"2024-10-10",{"date":88,"type":69},"2026-10-30",{"name":5,"class":6},1]